The HSPA4 Knockout HeLa Polyclonal Cells are a ready-to-use human cell model featuring CRISPR/Cas9-mediated disruption of the HSPA4 gene within the HeLa cervical adenocarcinoma background. This polyclonal population comprises a pool of edited cells carrying diverse indel mutations at the target locus, collectively resulting in functional depletion of HSPA4 protein. The polyclonal format mitigates clonal artifacts and preserves population-level heterogeneity, making it well-suited for studies requiring robust and reproducible loss-of-function phenotypes.
HeLa is one of the most widely employed human cell lines, originating from an HPV-18-positive cervical adenocarcinoma. These adherent epithelial cells exhibit unlimited replicative potential and have been instrumental in advances across oncology, infectious disease, and cellular biochemistry. The parental line??s well-annotated genome, ease of transfection, and compatibility with high-throughput screens render it an ideal host for gene editing and pathway analysis. HSPA4 knockout in this context enables dissection of stress response mechanisms directly in a disease-relevant model.
HSPA4 encodes a member of the heat shock protein 70 (HSP70) family that functions as an ATP-dependent molecular chaperone. It is transcriptionally upregulated by HSF1 in response to heat shock, oxidative stress, heavy metals, and proinflammatory cytokines such as TNF-alpha. HSPA4 cooperates with co-chaperones including BAG3, DNAJB1, and the E3 ubiquitin ligase STUB1/CHIP to refold misfolded proteins or target them for proteasomal degradation. Beyond proteostasis, HSPA4 modulates NF-??B signaling through interaction with the IKK complex and regulates the intrinsic apoptotic pathway by binding Apaf-1 and influencing caspase-9 activation. Thus, HSPA4 sits at a critical node integrating stress adaptation with survival and immune signaling networks.
Within the HeLa adenocarcinoma model, loss of HSPA4 function compromises the cellular ability to withstand proteotoxic insults and maintain oncogenic signaling. Consequent impairment of chaperone-assisted protein folding is anticipated to sensitize cells to chemotherapeutic agents, proteasome inhibitors, and hypoxia, while disrupting NF-??B-mediated transcription and apoptotic thresholds. This knockout therefore serves as a powerful tool for interrogating the roles of HSP70 chaperones in tumor cell fitness, drug resistance, and the unfolded protein response, as well as for validating potential pharmacological inhibitors of the HSP70 system.
Applications span from fundamental investigation of protein quality control to translational oncology and immune modulation. Researchers can employ this model in western blot and RT-qPCR analyses to confirm HSPA4 depletion, co-immunoprecipitation to map chaperone-client interactions, and immunofluorescence for subcellular localization under stress. Functional readouts include Annexin V flow cytometry for apoptosis, NF-??B luciferase reporter assays, cell viability monitoring following heat shock or heavy metal exposure, and chaperone or proteasome activity measurements. These cells are also suitable for combinatorial drug screens targeting HSP70-dependent vulnerabilities and for dissecting HSPA4??s contribution to antigen presentation and MAPK signaling. For additional information or customized support, please contact Ascent Research.
